Page last updated: 2024-09-04

atazanavir sulfate and Muscular Weakness

atazanavir sulfate has been researched along with Muscular Weakness in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bagella, P; Bonfanti, P; Carenzi, L; Celesia, BM; De Socio, GV; Dentone, C; Di Biagio, A; Franzetti, M; Libertone, R; Madeddu, G; Maggi, P; Martinelli, C; Orofino, G; Parruti, G; Penco, G; Quirino, T; Ricci, E; Vichi, F	1

Other Studies

1 other study(ies) available for atazanavir sulfate and Muscular Weakness

Article	Year
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance. International journal of antimicrobial agents, 2015, Volume: 45, Issue:3 Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Creatine Kinase; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Incidence; Male; Middle Aged; Muscle Weakness; Myalgia; Oligopeptides; Prospective Studies; Pyridines; Pyrrolidinones; Raltegravir Potassium	2015

Article

Year

Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance.

International journal of antimicrobial agents, 2015, Volume: 45, Issue:3

Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Creatine Kinase; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Incidence; Male; Middle Aged; Muscle Weakness; Myalgia; Oligopeptides; Prospective Studies; Pyridines; Pyrrolidinones; Raltegravir Potassium

2015